George A. Eldridge
Equibles does not estimate personal net worth.
About George A. Eldridge
George A. Eldridge was last confirmed as CFO at Jade Biosciences, Inc. (JBIO) in a filing dated April 29, 2022. Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that George A. Eldridge was terminated as Aerovate's Chief Financial Officer, effective April 28, 2025. The proxy statement of Jade Biosciences, Inc. reports total compensation of $1,690,904 for George A. Eldridge in fiscal 2021, including a base salary of $300,785.
“Each of Timothy P. Noyes, Aerovate's Chief Executive Officer, and George A. Eldridge, Aerovate's Chief Financial Officer, resigned as executive officers at the Closing and their employment was terminated effective April 28, 2025 (the "Separation Date"), which terminations are considered to be without "cause" related to a change in control for purposes of their employment agreements with Aerovate.”
Affiliation history
-
Start not stated–2022-04-29
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Jade Biosciences, Inc. (JBIO) | Chief Financial Officer | $300,785 | $1,690,904 |